Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$5.23 - $7.82 $230,120 - $344,080
-44,000 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$7.29 - $10.97 $109,350 - $164,550
-15,000 Reduced 25.42%
44,000 $330,000
Q3 2021

Nov 10, 2021

SELL
$9.01 - $12.01 $72,080 - $96,080
-8,000 Reduced 11.94%
59,000 $532,000
Q2 2021

Aug 16, 2021

SELL
$10.17 - $12.64 $71,190 - $88,480
-7,000 Reduced 9.46%
67,000 $802,000
Q1 2021

May 17, 2021

SELL
$10.88 - $17.05 $65,280 - $102,300
-6,000 Reduced 7.5%
74,000 $927,000
Q4 2020

Feb 16, 2021

SELL
$9.23 - $18.18 $32,305 - $63,630
-3,500 Reduced 4.19%
80,000 $1.25 Million
Q2 2020

Aug 11, 2020

BUY
$6.21 - $11.83 $208,035 - $396,305
33,500 Added 67.0%
83,500 $748,000
Q1 2020

May 15, 2020

BUY
$5.05 - $8.85 $60,600 - $106,200
12,000 Added 31.58%
50,000 $319,000
Q2 2019

Aug 14, 2019

SELL
$8.75 - $13.03 $26,250 - $39,090
-3,000 Reduced 7.32%
38,000 $409,000
Q1 2019

May 13, 2019

SELL
$7.72 - $12.81 $92,640 - $153,720
-12,000 Reduced 22.64%
41,000 $391,000
Q3 2018

Nov 13, 2018

BUY
$13.05 - $19.05 $13,050 - $19,050
1,000 Added 1.92%
53,000 $898,000
Q2 2018

Jul 03, 2018

BUY
$13.9 - $19.8 $83,400 - $118,800
6,000 Added 13.04%
52,000 $738,000
Q1 2018

May 14, 2018

BUY
$16.7 - $26.35 $768,200 - $1.21 Million
46,000 New
46,000 $0

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $50.1M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Cito Capital Group, LLC Portfolio

Follow Cito Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cito Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cito Capital Group, LLC with notifications on news.